Hormone replacement therapy in Denmark, 1995-2004

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 11, 2007, Pages 1342-1351

  Løkkegaard, Ellen ^a,d   Lidegaard, Øjvind ^a,b   Møller, Lisbeth Nørgaard ^c   Agger, Carsten ^c   Andreasen, Anne Helms ^c   Jørgensen, Torben ^c  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Anatomical Therapeutical Chemical; Conjugated equine estrogen; Cyproteroneacetate; Defined daily doses; Hormone Replacement Therapy; Intrauterine device; Medroxyprogesterone acetate; National Register of Medicinal Product Statistics; Norethisterone acetate

Indexed keywords

ANDROGEN; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; CONJUGATED ESTROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTRIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; RALOXIFENE; TIBOLONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DRUG MEGADOSE; EDUCATION; EMPLOYMENT; ESTROGEN THERAPY; FEMALE; GYNECOLOGIC SURGERY; HABITUATION; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; DENMARK; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEALTH STATUS; HUMANS; MIDDLE AGED; PROGESTINS; REGISTRIES; SOCIOECONOMIC FACTORS;

EID: 35648954236     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701505523     Document Type: Article

References (8)

1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comments]. JAMA. 1998;280(7):605-13.
2. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.
3. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG. 2002;109(12):1319-30.
4. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol. 1997;145(6):536-45.
5. Hundrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand. 2000;79(3):194-201.
6. Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas. 2001;40(2):131-41.
7. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal Hormone Replacement Therapy after the publication of clinical trial results. Ann Intern Med. 2004;140(3):184-8.
8. Lokkegaard EL, Johnsen SP, Heitmann BL, Stahlberg C, Pedersen AT, Obel EB, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand. 2004;83(5):476-81.